MARCO and lung carcinoma: Indeed, antibody-mediated blockade of MARCO and IL-37R, or CRISPR knockout of IL-37 in lung cancer cells, altered TAM phenotypes, resulting in reduced activity of regulatory T cells and enhanced cytotoxic function of both NK and T cells [74].